apobec enzyme Search Results


human dna dc->du-editing enzyme apobec-3f, apobec3f genlisa elisa  (Krishgen Biosystems)
N/A
ELISA for estimation of Human DNA dC->dU-editing Enzyme APOBEC-3F, APOBEC3F in serum, plasma and other biological fluids
   Buy from Supplier
foxl2 antibody  (Boster Bio)
93
Boster Bio foxl2 antibody
Primers Used for Real-Time Polymerase Chain Reaction
Foxl2 Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/apobec+enzyme/pmc04281840-56-0-4?v=Boster+Bio
Average 93 stars, based on 1 article reviews
foxl2 antibody - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier
amino acids 345 354 knnlkdcglf  (ProSci Incorporated)
90
ProSci Incorporated amino acids 345 354 knnlkdcglf
Primers Used for Real-Time Polymerase Chain Reaction
Amino Acids 345 354 Knnlkdcglf, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/apobec+enzyme/pm29182502-75-10-25?v=ProSci+Incorporated
Average 90 stars, based on 1 article reviews
amino acids 345 354 knnlkdcglf - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
enzymes such as aid/ apobec  (Chemie GmbH)
90
Chemie GmbH enzymes such as aid/ apobec
Primers Used for Real-Time Polymerase Chain Reaction
Enzymes Such As Aid/ Apobec, supplied by Chemie GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/apobec+enzyme/pm22744788-520-0-26?v=Chemie+GmbH
Average 90 stars, based on 1 article reviews
enzymes such as aid/ apobec - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
human dna dc->du-editing enzyme apobec-3g, apobec3g genlisa elisa  (Krishgen Biosystems)
N/A
ELISA for estimation of Human DNA dC->dU-editing Enzyme APOBEC-3G, APOBEC3G in serum, plasma and other biological fluids
   Buy from Supplier
recombinant human probable dna dc->du-editing enzyme apobec-3c  (Cusabio)
N/A
   Buy from Supplier
recombinant human dna dc->du-editing enzyme apobec-3a  (Cusabio)
N/A
   Buy from Supplier

Image Search Results


Primers Used for Real-Time Polymerase Chain Reaction

Journal: DNA and Cell Biology

Article Title: microRNA133a Targets Foxl2 and Promotes Differentiation of C2C12 into Myogenic Progenitor Cells

doi: 10.1089/dna.2014.2522

Figure Lengend Snippet: Primers Used for Real-Time Polymerase Chain Reaction

Article Snippet: FOXL2 antibody was from Boster Biotechnology.

Techniques: Sequencing

Foxl2 is a direct target of miR-133a. (A) Predicted miR-133a binding sites in Foxl2 3′UTR. Specific locations of the binding sites were marked with red color, and Foxl2 3′UTR was marked with blue color. (B) Alignment between the predicted miR-133a target sites and miR-133a is shown. The conserved, 7-bp seed sequence for miR-133a:mRNA pairing is also indicated. (C) Diagram depicting the pMIR luciferase reporter constructs, containing a cytomegalovirus (CMV) promoter, which was utilized to verify the putative miR-133a binding sites. Luc, luciferase; poly A, poly(A) tail. (D) HEK293 cells were cotransfected with miR-133a, pLuc-FOXL2 3′UTR, along with a pRL-TK reporter plasmid. After 24 h, the luciferase activity was measured. Values are presented as relative luciferase activity after normalization to Renilla luciferase activity. The data are expressed as the mean value±S.E. (error bars) of the results obtained from three independent experiments. *Differences in luciferase activity between miR-133a and negative control transfected cells were significant, p<0.05. (E) Foxl2 expression levels in C2C12 cells after transfection with miR-133a were determined by western blot analysis. As compared with the NC miRNA, miR-133a expression reduced the levels of Foxl2 in C2C12 cells. GAPDH was used as an internal control. Foxl2, forkhead transcriptional factor 2; UTR, untranslated region.

Journal: DNA and Cell Biology

Article Title: microRNA133a Targets Foxl2 and Promotes Differentiation of C2C12 into Myogenic Progenitor Cells

doi: 10.1089/dna.2014.2522

Figure Lengend Snippet: Foxl2 is a direct target of miR-133a. (A) Predicted miR-133a binding sites in Foxl2 3′UTR. Specific locations of the binding sites were marked with red color, and Foxl2 3′UTR was marked with blue color. (B) Alignment between the predicted miR-133a target sites and miR-133a is shown. The conserved, 7-bp seed sequence for miR-133a:mRNA pairing is also indicated. (C) Diagram depicting the pMIR luciferase reporter constructs, containing a cytomegalovirus (CMV) promoter, which was utilized to verify the putative miR-133a binding sites. Luc, luciferase; poly A, poly(A) tail. (D) HEK293 cells were cotransfected with miR-133a, pLuc-FOXL2 3′UTR, along with a pRL-TK reporter plasmid. After 24 h, the luciferase activity was measured. Values are presented as relative luciferase activity after normalization to Renilla luciferase activity. The data are expressed as the mean value±S.E. (error bars) of the results obtained from three independent experiments. *Differences in luciferase activity between miR-133a and negative control transfected cells were significant, p<0.05. (E) Foxl2 expression levels in C2C12 cells after transfection with miR-133a were determined by western blot analysis. As compared with the NC miRNA, miR-133a expression reduced the levels of Foxl2 in C2C12 cells. GAPDH was used as an internal control. Foxl2, forkhead transcriptional factor 2; UTR, untranslated region.

Article Snippet: FOXL2 antibody was from Boster Biotechnology.

Techniques: Binding Assay, Sequencing, Luciferase, Construct, Plasmid Preparation, Activity Assay, Negative Control, Transfection, Expressing, Western Blot, Control

Expression of miRNAs and Foxl2 after using 2% HS differentiation of C2C12 cells for 5 days and Foxl2 knockdown by siRNA. (A) Quantitative analysis of miR-1, miR-133a, and miR-206 by real-time PCR. (B) Quantitative analysis of Foxl2 by real-time PCR. (C) Foxl2 protein expression. (D) Quantitative analysis of Foxl2 by real-time PCR. (E) Quantitative analysis of MyoD, MyHC, MyoG, Caldesmon, and MAML1 by real-time PCR. **p<0.01, *p<0.05.

Journal: DNA and Cell Biology

Article Title: microRNA133a Targets Foxl2 and Promotes Differentiation of C2C12 into Myogenic Progenitor Cells

doi: 10.1089/dna.2014.2522

Figure Lengend Snippet: Expression of miRNAs and Foxl2 after using 2% HS differentiation of C2C12 cells for 5 days and Foxl2 knockdown by siRNA. (A) Quantitative analysis of miR-1, miR-133a, and miR-206 by real-time PCR. (B) Quantitative analysis of Foxl2 by real-time PCR. (C) Foxl2 protein expression. (D) Quantitative analysis of Foxl2 by real-time PCR. (E) Quantitative analysis of MyoD, MyHC, MyoG, Caldesmon, and MAML1 by real-time PCR. **p<0.01, *p<0.05.

Article Snippet: FOXL2 antibody was from Boster Biotechnology.

Techniques: Expressing, Knockdown, Real-time Polymerase Chain Reaction